230722 Lancet Building Africa's first mRNA vaccine facility
For Africa, mRNA vaccines are beneficial and could be used to combat various bacterial and viral infections other than COVID-19 in the continent. mRNA vaccines can be produced in large quantities and are efficient and safe. Moreover, these vaccines can also be produced quickly, with minimal effort and without previous knowledge of biological pharmacological agents. With mRNA technology, malaria and tuberculosis vaccines can be developed, giving African nations good chances to fight these diseases endemic to the region.
Evaluation of the Strategic Advisory Group of Experts (SAGE) on Immunization (2019)